Patient adherence in Germany - benefit vs. cost-containment

51 minutes

Register to watch now

June 24, 2015

Register Save to Calendar

In a healthcare economy that is under pressure to provide cost savings, biopharma must demonstrate a long-term commitment to supporting health systems through effective adherence support programs. This Quintiles sponsored webcast will cover key topics including which patient adherence programs have been successful in Germany and elaborate on the specifics of engaging in patient support programs in the German market. Particular attention will be given to the legal and regulatory challenges facing biopharma wanting to tackle the German market. The webcast will also cover the benefit of adherence programs from the payer perspective, with an overview of the German sick-fund landscape and cost allocation challenges.

This webinar sponsored by Quintiles, will bring together a German patient support expert from Quintiles and a representative from the renowned IGES Institute for research and consulting in healthcare from Germany to provide valuable insight on this topical biopharma debate.

Key Learning Objectives:

  • Uncover best practice approaches to patient adherence programs in the German healthcare market
  • Explore the regulatory perspective on how to provide beneficial patient adherence programs in Germany
  • Discover what makes a successful patient adherence program based on observation and experience of implementing programs in Germany

Who Should Attend:

Decision makers in Market Access, Regulatory Affairs, Real-World / Late Phase research, HEOR, patient-centric / patient engagement programs, payer / provider relations, Brand managers, Marketing Managers/Directors, Pricing & Reimbursement, Medial Affairs, Executive Management, Health Technology Assessment, Pharmacovigilance


Hans Holger Bleß
Director of Health Services Research
IGES Institut GmbH

Joanne Thiele
Market Access Project Manager